IPMN Involving the Main Pancreatic Duct: Biology, Epidemiology, and Long-term Outcomes Following Resection

Annals of Surgery

Volumn 261, Issue 5, 2015, Pages 976-983

  Marchegiani, Giovanni ^a   Mino Kenudson, Mari ^a   Sahora, Klaus ^a   Morales Oyarvide, Vicente ^a   Thayer, Sarah ^a   Ferrone, Cristina ^a   Warshaw, Andrew L ^a   Lillemoe, Keith D ^a   Castillo, Carlos Fernández Del ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

cystic neoplasm; intraductal papillary mucinous neoplasm; IPMN; MD IPMN; pancreas

Indexed keywords

ADULT; AGED; ARTICLE; BIOLOGY; CANCER SURVIVAL; DISEASE SPECIFIC SURVIVAL; DYSPLASIA; FEMALE; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS DUCT; PHENOTYPE; POSTOPERATIVE COMPLICATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR RECURRENCE; ADENOCARCINOMA, MUCINOUS; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; DISEASE FREE SURVIVAL; LYMPH NODE; METASTASIS; MORTALITY; PATHOLOGY; TUMOR INVASION;

ADENOCARCINOMA, MUCINOUS; AGED; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODES; MALE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PANCREATIC DUCTS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84942548178     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000813     Document Type: Article

References (41)

1. Sohn TA, Yeo CJ, Cameron JL, Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg. 2001; 234: 313-321; discussion 321-322.
2. Kloppel G, Solcia E, Longnecker DS,. Histological typing of tumors of the exocrine pancreas: World Health Organization International Histological Classification of Tumors. 2nd ed. New York, NY: Springer Verlag; 1996.
3. Ohhashi K, Murakami Y, Murayama M, Four cases of mucin-producing cancer of the pancreas on specific findings of the papilla of Vater. Prog Dig Endosc. 1982; 20: 348-351.
4. Kobari M, Egawa S, Shibuya K, Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg. 1999; 134: 1131-1136.
5. Fernandez-del Castillo C, Adsay NV,. Intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology. 2010; 139: 708.e1-713.e2.
6. Rodriguez JR, Salvia R, Crippa S, Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology. 2007; 133: 72-79; quiz 309-310.
7. Farrell JJ, Fernandez-del Castillo C,. Pancreatic cystic neoplasms: management and unanswered questions. Gastroenterology. 2013; 144: 1303-1315.
8. Salvia R, Fernandez-del Castillo C, Bassi C, Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004; 239: 678-685; discussion 685-687.
9. Valsangkar NP, Morales-Oyarvide V, Thayer SP, 851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital. Surgery. 2012; 152 (Suppl 1): S4-S12.
10. Maguchi H, Tanno S, Mizuno N, Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan. Pancreas. 2011; 40: 364-370.
11. Tanaka M, Chari S, Adsay V, International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006; 6: 17-32.
12. Tanaka M, Fernandez-del Castillo C, Adsay V, International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012; 12: 183-197.
13. Sahora K, Mino-Kenudson M, Brugge W, Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg. 2013; 258: 466-475.
14. Crippa S, Fernandez-Del Castillo C, Salvia R, Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol. 2010; 8: 213-219.
15. Salvia R, Malleo G, Marchegiani G, Pancreatic resections for cystic neoplasms: from the surgeon's presumption to the pathologist's reality. Surgery. 2012; 152: S135-S142.
16. Sahora K, Fernandez-del Castillo C, Dong F,. Not all combined intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct. Surgery. 2014; 156: 611-621.
17. Adsay NV, Kloppel G, Fukushima N, Intraductal neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, eds. World Health Organization Classification of tumors, pathology, and genetics of tumors of the digestive system. Lyon, France: IARC Press; 2010: 304-313.
18. Furukawa T, Kloppel G, Volkan Adsay N, Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005; 447: 794-799.
19. Furukawa T, Hatori T, Fujita I, Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut. 2011; 60: 509-516.
20. Ban S, Naitoh Y, Mino-Kenudson M, Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am J Surg Pathol. 2006; 30: 1561-1569.
21. Mino-Kenudson M, Fernandez-del Castillo C, Baba Y, Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut. 2011; 60: 1712-1720.
22. Distler M, Kersting S, Niedergethmann M, Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg. 2013; 258: 324-330.
23. Nara S, Shimada K, Kosuge T, Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Am J Surg Pathol. 2008; 32: 243-255.
24. Biankin AV, Kench JG, Biankin SA, Pancreatic intraepithelial neoplasia in association with intraductal papillary mucinous neoplasms of the pancreas: implications for disease progression and recurrence. Am J Surg Pathol. 2004; 28: 1184-1192.
25. Ideno N, Ohtsuka T, Kono H, Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ann Surg. 2013; 258: 141-151.
26. Yamaguchi K, Kanemitsu S, Hatori T, Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas. 2011; 40: 571-580.
27. TNM Staging 7th edition [database online]. Adams County, PA: American Joint Committee on Cancer. 2010. Available at: http://www.cancerstaging.org. Accessed June 10, 2014.
28. Bassi C, Dervenis C, Butturini G, Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005; 138: 8-13.
29. Tamura K, Ohtsuka T, Ideno N, Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review. Ann Surg. 2014; 259: 360-368.
30. Takuma K, Kamisawa T, Anjiki H, Predictors of malignancy and natural history of main-duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2011; 40: 371-375.
31. Mohri D, Asaoka Y, Ijichi H, Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression. J Gastroenterol. 2012; 47: 203-213.
32. Kim J, Jang KT, Mo Park S, Prognostic relevance of pathologic subtypes and minimal invasion in intraductal papillary mucinous neoplasms of the pancreas. Tumour Biol. 2011; 32: 535-542.
33. Correa-Gallego C, Do R, Lafemina J, Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram. Ann Surg Oncol. 2013; 20: 4348-4355.
34. Abdeljawad K, Vemulapalli KC, Schmidt CM, Prevalence of malignancy in patients with pure main duct intraductal papillary mucinous neoplasms. Gastrointest Endosc. 2014; 79: 623-629.
35. Nakata K, Ohuchida K, Aishima S, Invasive carcinoma derived from intestinal-type intraductal papillary mucinous neoplasm is associated with minimal invasion, colloid carcinoma, and less invasive behavior, leading to a better prognosis. Pancreas. 2011; 40: 581-587.
36. Yopp AC, Katabi N, Janakos M, Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma. Ann Surg. 2011; 253: 968-974.
37. Kang MJ, Lee KB, Jang JY, Evaluation of clinical meaning of histological subtypes of intraductal papillary mucinous neoplasm of the pancreas. Pancreas. 2013; 42: 959-966.
38. Ingkakul T, Sadakari Y, Ienaga J, Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg. 2010; 251: 70-75.
39. Couvelard A, Sauvanet A, Kianmanesh R, Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable: a prospective evaluation. Ann Surg. 2005; 242: 774-778; discussion 778-780.
40. White R, D'Angelica M, Katabi N, Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. J Am Coll Surg. 2007; 204: 987-993; discussion 993-995.
41. Fujii T, Kato K, Kodera Y, Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas. Surgery. 2010; 148: 285-290.